Pharmaceutical

Sonnet BioTherapeutics secures US patent covering two drug candidates

Sonnet BioTherapeutics has announced the issuance of US Patent No. 12,134,635 covering its two new drug candidates, SON-1411 and SON-1400, expected to advance treatment options for cancer.

Nov 9, 2024 - 06:00
Sonnet BioTherapeutics secures US patent covering two drug candidates
Sonnet BioTherapeutics has announced the issuance of US Patent No. 12,134,635 covering its two new drug candidates, SON-1411 and SON-1400, expected to advance treatment options for cancer.
Read the original article

Tags:

Previous Article

Mustang Bio’s MB-108 receives FDA orphan drug status for glioma treatment

Next Article

Santen, Arctic Vision sign deal for ARVN001 to treat UME

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Gene therapy: How the CRO of Veristat cut trial database costs by 30%

Gene therapy: How the CRO of Veristat cut trial databas...

Jul 18, 2024

Gail Wilensky on the Geisinger deal, the earnings bonanza, and medical credit cards proliferate

Gail Wilensky on the Geisinger deal, the earnings bonan...

May 9, 2023

Why did Allogene cancel two clinical trials for its off-the-shelf cell therapy?

Why did Allogene cancel two clinical trials for its off...

Jan 6, 2024